[1]Hara T, Kosaka N, Kondo T, et al. Imaging of brain tumor, lung cancer, esophagus cancer, colon cancer, prostate cancer, and bladder cancer with [C-11]choline [abstract][J]. J Nucl Med,1997, 38(suppl): 250.
[2]Ceci F, Castellucci P, Graziani T, et al. 11C-choline PET/CT identifies osteoblastic and osteolytic lesions in patients with metastatic prostate cancer[J]. Clinical Nuclear Medicine,2015, 40(5): 265-270.
[3]DeGrado T R, Coleman R E, Wang S, et al. Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer[J]. Cancer Res, 2001, 61: 110-117.
[4]Hara T, Kosaka N, Kishi H. Development of 18F-Fluor oethy lcholine for cancer imaging with PET: synthesis, biochemistry, and prostate cancer imaging[J]. J Nucl Med, 2002, 43(1) : 187-199.
[5]Bauman G, Belhocine T, Kovacs M, et al. 18F-fluorocholine for prostate cancer imaging: a systematic review of the literature[J]. Prostate Cancer Prostatic Dis, 2012,15 (1): 45-55.
[6]Cédric M, Ludovic F, Thomas C, et al. Assessment of lymph nodes and prostate status using early dynamic curves with (18)F-Choline PET/CT in prostate cancer[J]. Frontiers in Medicine, 2015, 2: 67-73.
[7]Colombié L, Campion C, Bailly D, et al. Prognostic value of metabolic parameters and clinical impact of (18)F-fluorocholine PET/CT in biochemical recurrent prostate cancer[J]. European Journal of Nuclear Medicine and Molecular Imaging, 2015, 12: 1 784-1793.
[8]Shao X, Hockley B G, Hoareau R, et al. Fully automated preparation of [11C]choline and [18F]fluoromethyl-choline using TracerLab synthesis modules and facilitated quality control using analytical HPLC[J]. Appl Rad Isotop, 2011, 69: 403-409.
[9]Sperandeo A, Cistaro A, Paligoric N, et al. Automated synthesis of 18F-Fluorocholine with synthesis module TRACERLAB (fx) FDG[J]. J Nucl Med,2009, 50(Suppl 2): 28.
[10]Cornford E M, Braun L D, Oldendorf W H. Carrier mediated blood-brain barrier transport of choline and certain choline analogs[J]. J Neurochem, 1978, 30: 299-308.
[11]Slaets D, De Bruyne S, Dumolyn C. Reduced dimethylaminoethanol in [18F]fluoromethylcholine: an important step towards enhanced tumor visualization[J]. Eur J Nuc Med Mol Imaging, 2010, 37: 2136-2145.
[12]Melissa E R, Allen F B, Brian G H,et al. A Fully-automated one-pot synthesis of [18F]Fluoromethylcholine with reduced dimethylaminoethanol contamination via [18F]Fluoromethy l tosylate[J]. Appl Radiat Isot, 2013, 78: 26-32.
[13]Neal T R, Apana S, Berridge M S. Improved synthesis of [18F]fluoromethyl tosylate, a convenient reagent for radiofluoromethylations[J]. J Label Compd Radiopharm, 2005, 48: 557-568.
[14]吴战宏,王世真,周前,等. 18F标记氟甲基胆碱的半自动合成及其生物分布[J]. 核化学与放射化学,2005,27(3):185-188.Wu Zhanhong, Wang shizhen, Zhou Qian, et al. Semi-automatic synthesis and biological evaluation of 18F-FCH as an oncologic PET tracer[J]. Journal of Nuclear and Radiochemistry, 2005, 27(3): 185-188(in Chinese).
[15]Iwata R, Pascali C, Bogni A, et al. [18F]fluoromethyl triflate, a novel and reactive [18F]fluoromethylating agent:, preparation and application to the on-column preparation of [18F]fluorocholine[J]. Appl Radiat Isot, 2002, 57: 347-352.
[16]DeGrado T R, Baldwin S W, Wang S, et al. Synthesis and evaluation of 18F-Labeled choline analogs as oncologic PET tracers[J]. J Nucl Med, 2001, 42: 1805-1814.
[17]郭喆,张锦明. 胆碱在11C-胆碱在PET肿瘤显像中的应用[J]. 同位素,2005,18(3):178-182.Guo Zhe , Zhang Jinming. Application of 11C-choline PET in tumors imaging[J].Journal of Isotopes, 2005, 18(3): 178-182(in Chinese). |